LifeStance Health Group, Inc.: Form 10-Q for the period ended Jun 30, 2022
Filed with the SEC on Aug 10, 2022 and accepted by EDGAR at Aug 10, 2022, 16:37 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-04-01 to 2022-06-30 | $209.5m | us-gaap:Revenues |
| Revenue | 6 months2022-01-01 to 2022-06-30 | $412.6m | us-gaap:Revenues |
| Selling, general and administrative | 3 months2022-04-01 to 2022-06-30 | $103.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2022-01-01 to 2022-06-30 | $206.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-04-01 to 2022-06-30 | −$60.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2022-01-01 to 2022-06-30 | −$125.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-04-01 to 2022-06-30 | $7.1m | us-gaap:InterestExpense |
| Interest expense | 6 months2022-01-01 to 2022-06-30 | $10.6m | us-gaap:InterestExpense |
| Income tax | 3 months2022-04-01 to 2022-06-30 | $923.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2022-01-01 to 2022-06-30 | −$5.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-04-01 to 2022-06-30 | −$68.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2022-01-01 to 2022-06-30 | −$131.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months2022-01-01 to 2022-06-30 | $11.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2022-01-01 to 2022-06-30 | $53.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-06-30 | $96.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-06-30 | $244.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-06-30 | $1.97bn | us-gaap:Assets |
| Current liabilities | At period end2022-06-30 | $111.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-06-30 | $437.4m | us-gaap:Liabilities |
| Long-term debt | At period end2022-06-30 | $203.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-06-30 | $1.5m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-06-30 | $1.53bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-22-016508. Last ingested by Listed: Nov 10, 2026, 19:02 ET. Listed shows no prices and gives no investment advice.